Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
941 Ergebnisse für "sufficient" unter Somagenetix
Neuronal ensembles sufficient for recovery sleep and the sedative a...
... Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists ... receptor-induced sedation and recovery sleep share hypothalamic circuitry sufficient for producing these ... Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists ... Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists ... Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists ...
Active receptor tyrosine kinases, but not Brachyury, are sufficient...
... sufficient to transform notochord cells. Aberrant activation of RTK/Ras signaling attenuates processes ... and Kdr/VEGFR2 are sufficient to transform notochord cells. Aberrant activation of RTK/Ras signaling ... Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in ... Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in ... Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
1303 Ergebnisse für "sufficient" unter University of Zurich
Low allopurinol doses are sufficient to optimize azathioprine thera...
... Maintenance Infos Low allopurinol doses are sufficient to optimize azathioprine therapy in ... , Alexander (2013). Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory ... Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease ... Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease ... Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease ...
A 2-kb c-mpl promoter fragment is sufficient to direct expression t...
... A 2-kb c-mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and ... -mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and sites of ... A 2-kb c-mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and ... A 2-kb c-mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and ... A 2-kb c-mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1142 Ergebnisse für "sufficient" unter ETH Entrepreneurship
Servers – IT Service Group of the Department of Computer Science | ...
... server installations: Virtual or Physical Server Virtual servers are sufficient for many purposes and ... . Virtual or Physical Server Virtual servers are sufficient for many purposes and have many advantages: For ...
01 – Group for Sustainability and Technology | ETH Zurich
... Researchers from SusTec have assessed the how, when and where of self- sufficient energy supply to a ... energy self- sufficient neighborhoods published Researchers from SusTec have assessed the how, when and ... where of self- sufficient energy supply to a solar-powered neighborhood. 25.01.2018 by Franz Radke ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
116 Ergebnisse für "sufficient" unter Roche Glycart AG
cobas® cfDNA Sample Preparation Kit
... can isolate genomic DNA from plasma in < 2 hours Only 2 mL of plasma is needed to provide sufficient ... can isolate genomic DNA from plasma in < 2 hours Only 2 mL of plasma is needed to provide sufficient ...
cobas® cfDNA Sample Preparation Kit
... hours Only 2 mL of plasma is needed to provide sufficient cfDNA to perform the cobas® mutation tests The ... genomic DNA from plasma in < 2 hours Only 2 mL of plasma is needed to provide sufficient cfDNA to perform ...
Swiss Bioscience GmbH
https://www.swissbioscience.com/
8952 Schlieren, Wagistrasse 27a
+41 (0) 44 731 99 00
info@swissbioscience.com
Swiss Bioscience GmbH manufactures and banks stem cells for individuals and provides pharmaceutical grade SVF* and hADSCs** produced under cGMP*** conditions. (* Stromal Vascular Fraction extracted from human lipoaspirate, ** Human Adipose Tissue Derived Stem Cells, *** Current Good Manufacturing Practice)
Swiss Bioscience GmbH
Wagistrasse 27a
8952 Schlieren
2 Ergebnisse für "sufficient" unter Swiss Bioscience GmbH
SBS | Stem Cells
... cases either the quantity of mobilised stem cells is not sufficient or time to mobilisation is too long ... . However, in many cases either the quantity of mobilised stem cells is not sufficient or time to ... cases either the quantity of mobilised stem cells is not sufficient or time to mobilisation is too long ... disease. However, in many cases either the quantity of mobilised stem cells is not sufficient or time to ...
Swiss Bioscience
... mobilised stem cells is not sufficient or time to mobilisation is too long. As a result the endogenous stem ... trauma or disease. However, in many cases either the quantity of mobilised stem cells is not sufficient ...
Repertoire Immune Medicines (Switzerland) AG
8952 Schlieren, Wagistrasse 27
The key to our strategy lies in understanding the inner workings of the immune synapse – the interaction between the T cell and the antigen presenting cell which dictates the immune code that tells a T cell to become toxic and to kill the infected tissue. Our scientists created and developed the DECODETM and DEPLOY suite of technologies, which allows in-depth characterization of TCR-antigen pairings – and the ability to rationally design and clinically develop targeted immune medicines. Our scientists also have developed novel technologies that attach potent immunomodulators to T cells, enabling us to deliver potent cytokines such as IL-15 or IL-12 directly to tumors by using the natural homing power of the T cells to traffic to diseased tissue.
Repertoire Immune Medicines (Switzerland) AG
Wagistrasse 27
8952 Schlieren
1 Ergebnisse für "sufficient" unter Repertoire Immune Medicines (Switzerland) AG
Manufacturing • Repertoire Immune Medicines
... generates a sufficient supply of drug product for multiple dosing of the patient. We began our first trial ... clones targeting multiple antigens. Each production run generates a sufficient supply of drug product for ...
BiognoSYS AG
8952 Schlieren, Wagistrasse 21
+41 44 738 20 40
info@biognosys.ch
BiognoSYS provides proteomics solutions to scientists and clinicians.
BiognoSYS AG
Wagistrasse 21
8952 Schlieren
10 Ergebnisse für "sufficient" unter BiognoSYS AG
iRT peptides volume calculator v2.xlsx
... contains 500 injection equivalents (IE) for a nano-flow LC. This means that one vial is sufficient for 500 ... equivalents (IE) for a nano-flow LC. This means that one vial is sufficient for 500 injections. * After ... contains 500 injection equivalents (IE) for a nano-flow LC. This means that one vial is sufficient for 500 ... equivalents (IE) for a nano-flow LC. This means that one vial is sufficient for 500 injections. * After ...
Sample Preparation Kit
... Buffer (1x 10 ml tube) The kit components are sufficient for 50 plasma or 50 cell culture sample ... sufficient for 50 plasma or 50 cell culture sample preparations to be made at once. It requires 10 µl per ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
68 Ergebnisse für "sufficient" unter University Hospital Zurich, Research and Education Office
Wyss Translational Center Zurich – UniversitätsSpital Zürich
... outside of the body in a perfusion machine until a sufficient size is reached; iii) retransplantation of ... perfusion systems are not able to keep a liver alive outside of the body for a sufficient time to allow ... machine until a sufficient size is reached; iii) retransplantation of the regenerated liver to the ... a liver alive outside of the body for a sufficient time to allow growth and regeneration to occur ...
Wyss Translational Center Zurich – UniversitätsSpital Zürich
... outside of the body in a perfusion machine until a sufficient size is reached; iii) retransplantation of ... perfusion systems are not able to keep a liver alive outside of the body for a sufficient time to allow ... machine until a sufficient size is reached; iii) retransplantation of the regenerated liver to the ... a liver alive outside of the body for a sufficient time to allow growth and regeneration to occur ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
16 Ergebnisse für "sufficient" unter CSL Vifor
Accessibility Statement
... , CSL may need sufficient notice to provide a reasonable accommodation. Technical Assistance In the ... the request, CSL may need sufficient notice to provide a reasonable accommodation. Technical ...
CSL Annual Report 2022 – Page 147
... responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis ... transactions and events in a manner that achieves fair presentation. ► Obtain sufficient appropriate audit ... sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material ... sufficient appropriate audit evidence regarding the financial information of the entities or business ...
